ONCOLOGY Nurse Edition Vol 23 No 11 | Oncology Nurse Edition

Young Adult Survivors Face Unique Challenges

October 09, 2009

There has been a growing recognition in recent years that young adults with cancer are a distinct demographic group with unique needs, issues, and challenges related to their age and developmental stage of life.

Challenges of IP Chemotherapy for Ovarian Cancer

October 09, 2009

Ms. Hydzik's article on intraperitoneal chemotherapy (IPC) for the treatment of ovarian cancer provides the rationale for IPC, presents the supporting evidence, and describes nursing management of these patients through the Memorial Sloan-Kettering Cancer Center experience.

Bevacizumab for Renal Cell Carcinoma,Glioblastoma, and Other Solid Tumors

October 09, 2009

In July 2009, the US Food and Drug Administration (FDA) granted approval for use of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin) in combination with interferon alfa for treatment of patients with metastatic renal cell carcinoma (RCC).